Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sagimet Announces Positive Results in NASH Trial of FASN Inhibitor TVB-2640

americanpharmaceuticalreviewJune 29, 2020

Tag: Sagimet Biosciences , FASN Inhibitor , TVB-2640 , NASH

PharmaSources Customer Service